Founded in April 2022 in Eindhoven, InnoFluidics leverages over a decade of R&D by founder Sertan Sukas. Focusing on continuous innovation for health, our expertise lies in device development. Initially dedicated to liquid biopsy for cancer prognosis and personalized medicine, our team manages all aspects from design to data processing in-house. InnoFluidics now extends its platform beyond cancer, offering an all-in-one solution for various analytical and biological applications. Our unique approach, handling everything internally, positions us as an ideal partner requiring only a problem definition from clients.